These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 14750222)
1. Fast track for antiretroviral. AIDS Patient Care STDS; 2003 Dec; 17(12):665. PubMed ID: 14750222 [No Abstract] [Full Text] [Related]
2. Fast track to MS drug. Sheridan C Nat Biotechnol; 2004 Aug; 22(8):939-41. PubMed ID: 15286635 [No Abstract] [Full Text] [Related]
3. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection. Krogstad PA J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216 [No Abstract] [Full Text] [Related]
4. Four-in-one HIV pill may be exception among combination drugs. Waters H Nat Med; 2011 Dec; 17(12):1528-9. PubMed ID: 22146434 [No Abstract] [Full Text] [Related]
6. FDA grants tentative approval to first generic version of antiretroviral Viread. AIDS Patient Care STDS; 2008 Jan; 22(1):86. PubMed ID: 18453039 [No Abstract] [Full Text] [Related]
7. Update on new antiretroviral drugs. An interview with Harold Kessler, M.D. by Matt Sharp. Kessler H Posit Aware; 2007; 18(6):22-4. PubMed ID: 18074429 [No Abstract] [Full Text] [Related]
8. WHO includes additional antiretroviral products in list of prequalified medicines. Saudi Med J; 2006 Apr; 27(4):576. PubMed ID: 16736570 [No Abstract] [Full Text] [Related]
9. A look ahead at this year's drug approvals. Proj Inf Perspect; 2007 Apr; (43):4-7. PubMed ID: 17684824 [No Abstract] [Full Text] [Related]
10. Is it time to rethink the expanded-access programs for HIV infection? Amorosa V; Tebas P J Infect Dis; 2007 Oct; 196(7):974-7. PubMed ID: 17763316 [TBL] [Abstract][Full Text] [Related]
11. Antiretroviral therapy: what about food? Agnarson AM; Ericson J; Ekström AM; Thorson A AIDS; 2007 May; 21(9):1225-6. PubMed ID: 17502741 [No Abstract] [Full Text] [Related]
12. I'm still the optimist. Burgess G Surviv News (Atlanta Ga); 2001 Dec; ():17. PubMed ID: 11802621 [No Abstract] [Full Text] [Related]
13. FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients. AIDS Alert; 2009 Sep; 24(9):106-7. PubMed ID: 19938313 [No Abstract] [Full Text] [Related]
14. Opinion paper. Resistance to new anti-HIV agents: problems in the pathway of drug registration. Dalmau D; Klimkait T; Telenti A Antivir Ther; 2005; 10(7):867-72. PubMed ID: 16312184 [TBL] [Abstract][Full Text] [Related]
15. Experimental drug quickly suppresses HIV. AIDS Read; 2005 Apr; 15(4):150. PubMed ID: 15844233 [No Abstract] [Full Text] [Related]
16. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)]. ; Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554 [No Abstract] [Full Text] [Related]
17. Generic nucleoside approved. AIDS Patient Care STDS; 2005 Aug; 19(8):540. PubMed ID: 16163787 [No Abstract] [Full Text] [Related]
18. Predicting and monitoring antiretroviral adherence. Gross R LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853 [TBL] [Abstract][Full Text] [Related]
19. AIDS treatment. Drugmakers test restrictions on generics in U.S. programs. Cohen J Science; 2004 Oct; 306(5694):213. PubMed ID: 15472049 [No Abstract] [Full Text] [Related]
20. T-1249 development hits a snag. AIDS Clin Care; 2004 Feb; 16(2):15. PubMed ID: 15032178 [No Abstract] [Full Text] [Related] [Next] [New Search]